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TISSUE TRANSPLANTATION
John G. Clark. M. B., Ch.B., F.R.C.S.E.
Departm ent o f Surgery, Roya l In firm a ry , Ed inburgh
H I S T O R I C A L  B A C K G R O U N D
T h e  transplantation o f tissues from  one site 
to another has been the sub ject o f surgical 
endeavour for m any centuries. S im p le  flap 
procedures for the repair o f defects in the skin 
o f the nose, m outh and cars w ere known to 
the G reeks and R o m an s o f the first century 
A .D ., and a form  o f rh inoplasty was carried 
o ut by Ind ian  surgeons, using local flaps, m ore 
than two thousand years ago. A  m ore sophis­
ticated technique o f rh inoplasty, involving the 
transfer o f a pedicled skin flap from  the arm , 
was used b y  T agliacozzi in the fourteenth 
century. Pow erfu l opposition to such inter­
ference in the works o f the A lm ig h ty  cam e 
from  the E cclesiastical authorities, and not 
only was T agliacozzi d iscredited , but further 
progress in this field was firm ly suppressed 
until the eighteenth century.
In 17 8 5 , in E d in b u rg h , a series o f experi­
m ents o f som e interest were carried out b y a 
certain M r. F ife  and other m em bers o f the 
R o yal M ed ica l Society, and their work is re­
corded in the So cie ty ’s E xp erim en ta l C o m ­
m ittee R ecords for that year.3 T h e y  were in­
terested in the possib ility o f blood transfusion, 
and used as their experim ental subjects pairs 
o f calves, one of each pair being bled via the 
carotid artery into a jugular vein o f the other. 
In one instance they used as a con duit a pair 
o f ivory cannulae connected b y  a piece of in­
testine w hich they had previously rem oved 
from  a eat, and on other occasions they used 
sim ple m etallic  tubes.
T h e  results o f their work are carefu lly  docu­
m ented and, since they preced ed Pasteur’s
discoveries by seventy-five years, and those of 
Lan d ste in e r on blood groups by one hundred 
and fifteen years, the experim enters m ay be 
excused for m arvelling th at the recipient 
anim als alm ost in variab ly took a vio lent rigor 
and expired shortly after the transfusion, and 
for con cluding that blood transfusion was not 
a practical procedure.
In the ensuing years num erous advances 
w ere m ade w hich m arked the d evelopm ent of 
transplantation surgery as w e know  it today. 
T h ro u gh o u t this period technical ab ility  has 
usually been m ore advanced than understand­
ing o f the fundam ental b iological problem s 
involved. T h u s  the n ineteenth  century saw 
developm ents in the field o f bone transplant­
ation, n otab ly by O ilier o f L yon s, w ho m ade 
observations on the fate o f bone fragm ents 
transplanted both subcutaneously and into 
skeletal defects, and noted the im portance of 
an intact periosteum  to the fate o f such grafts: 
and by M cE w e n  o f G lasgo w  w ho perform ed 
the first successful a llograft (v. infra) o f bone 
to reconstitute the hum eral shaft o f a child 
with osteom yelitis in 1878 . E arly  attem pts to 
transplant cornea, tendon, nerve, and cartilage 
w ere also m ade during the n ineteenth  century, 
b u t the transplantation of w hole organs on a 
vascular pedicle had to aw ait the developm ent 
of satisfactory techniques o f anastom osis o f 
blood vessels, an exercise that was not accom ­
plished w ith reliab ility  until the early part o f 
the tw entieth century.
A lth ou gh  H um p h rey D avey described the 
narcotic properties o f nitrous oxide in 179 8 , 
and suggested its possible use in surgery, 
alm ost half a century was to elapse before
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anaesthesia was applied , first in dentistry by 
W ells  and M orton  in the States, and later in 
surgery and m id w ifery by L iston  and Sim pson 
in Britain . T h ese  discoveries transform ed 
surgery from  the art o f the lightn ing craftsm an 
into a m ore leisurely exercise w hich w ould 
allow  the m ore tim e-consum ing and exacting 
work required for transplantation.
A n y tissue that is severed from  its blood 
supply in order to be placed in  a new situation 
passes through a period o f susceptibility to 
in fection , a com plication that was the fear o f 
n ineteenth century surgeons. T h e  discovery 
o f m icrobes in the 186 0 ’s led first to the 
eradication o f in fection by antiseptics and 
later to the notion that it was better to avoid 
it by the aseptic m ethod that is a corner stone 
o f m odern surgical technique. T h e  im port­
ance o f these events to transplantation surgery 
cannot be over em phasised, b u t w ithout the 
m ore recent discoveries o f sulphonam ides and 
antib iotic  substances in the 19 3 0 ’s and later, 
the advances that were to fo llow  the elucid­
ation of the im m unological rejection of trans­
plants from  one individual to another could 
not have taken place.
In the first two decades o f the tw entieth 
century there was m uch debate concerning 
the failure o f allografts o f tum our and norm al 
tissues to survive. T h ere  is not space here to 
discuss all the theories that were advanced, 
but am ong them  was the notion that the host 
developed an active im m unity to the graft. 
Several clin ical instances were reported o f the 
behaviour o f skin allografts used in burns and 
in extensive trauma during this period, but 
understanding that a failed allograft was 
fu ndam entally  different from  a failed auto­
graft was slow to develop. In 19 4 3  G ibson  and 
M ed ew ar 4 reported the accelerated rejection 
o f a second set of allografts from  the same 
donor to the sam e recipient in a case of burns, 
and this led on to M ed ew ar’s system atic study 
o f allografts published in 19 4 4  and 19 4 5 .5 “ 
H e established that in rabbits, such grafts were 
invariably rejected with a m ean survival tim e 
o f 10 .4  days, and that if a second graft was 
m ade from  the sam e donor to the sam e re­
cip ient twelve or m ore days after the first, re­
jection was accom plished m ore rapidly, with 
a m ean survival tim e of 6.0 days. H e also 
found that whereas first set grafts developed 
vascular connections and b ecam e infiltrated 
with m ononuclear cells prior to rejection, 
second set grafts o f skin failed to becom e 
vascularised at all; they rapidly becam e nec­
rotic, and such m ononuclear cells as were seen
were heavily am assed in the recipient tissue 
w hich was the graft bed.
I M M U N O L O G I C A L  T H E O R Y
T h ese  observations have been am ply con­
firm ed, and present day theory on transplant 
im m unity m ay be sum m arised as follow s: 
after the introduction of a graft into a recip­
ient anim al, m aterial from  the graft is carried 
into the host, cither in the form  o f soluble 
antigens w hich pass into the bloodsteam , or 
else by w ay of host m ononuclear cells w hich, 
on encountering the tissues of the graft, pick 
up antigenic m aterial and carry it via the 
bloodstream , or via lym ph atic channels, into 
the recip ient’s lym phoid tissues. Som e of 
these m ononuclear cells are m em bers o f the 
long-lived group o f lym phocytes in the peri­
pheral circulating pool, cells w hich arc con­
cerned in recognising foreign antigens. T h is  
m ay be referred to as the afferent m echanism .
A fferent antigenic m aterial gains contact 
with the lym phatic tissues of the host via the 
bloodstream , but in particular with the 
regional lym ph nodes which receive lym ph 
directly from  the graft. Lym ph ocytes in the 
paracortical areas o f the lym ph  nodes respond 
to the antigenic stim ulus brought to them by 
m acrophages returning from  the graft by trans­
form ing into a new, and now  high ly special­
ised group o f cells, w hich arc able to produce 
specific antibody to the antigens concerned. 
T h is  change is in som e w ay im printed o n  the 
genetic m echanism s o f the nucleus, so that 
the progeny o f such transform ed cells will 
possess this specific potentiality. T h ese  events 
m ay be called the central response.
T h ese  specialised cells m ay behave in two 
ways. Som e, rem aining in situ, produce spec­
ific antibody which passes into the circulation. 
O thers, m igrating from  their lym ph node 
origins, enter the blood stream  and are able 
to penetrate the graft where, by m echanism s 
unknow n, they exert a harm ful effect on the 
graft. Such is the effector m echanism  of 
transplantation im m unity. It should be em ­
phasised that a very great deal rem ains to be 
clarified about these im m une responses, in 
particular w ith regard to the role and inter­
relationships o f the cells involved; the fore­
going is no m ore than a b rief outline of pre­
valent theory. F o r m ore detailed in form ation , 
the interested reader is referred to the se ries 
o f articles by E . J. H olborow  in T h e  Lancet 
1967 N os. 7494-7503.
A t this stage the current nom enclature of
transplantation surgery m ust be introduced. 
A  graft transplanted from  one site  to another 
in the sam e in d iv idual is an autograft. I f  the 
recip ient is a m onozygous twin o f the donor, 
or a m em ber o f the sam e h igh ly  inbred strain 
in the case o f anim al w ork, then the term 
isograft is used. A  transplant to a d ifferent 
m em ber o f the sam e species, e.g. Jack  to Jill , 
is an a llograft, and w hen the donor belongs 
to a d ifferent species to the recip ient, e.g. 
baboon to m an, rat to m ouse, the term  xeno­
graft is used. T h e  last tw o o f these term s 
were form erly referred to as hom ografts and 
h eterografts respectively.
C lin ica l transplantation involves largely the 
use o f autografts and allografts. In the case 
o f paired organs, i.e. the k id ney, transplants 
betw een m onozygous twins are feasib le, and 
som e cases o f transplantation across species 
barriers have been reported. T h e  absence o f 
an im m unological problem  in  the case of 
autografts led to their w idespread adoption 
m any decades ago and the details o f their 
application  can be read in standard works on 
plastic and orthopaedic surgery.
M E TH O D S  OF IM M U N O S U P P R E S S IO N
T h e  fu ndam ental problem  to be overcom e 
in the case o f allografts is s im p ly  stated; the 
ab ility  o f the h o st’s im m unological m echan­
ism s to destroy the graft m ust b e  suppressed 
w ith ou t at the sam e tim e suppressing his im ­
m un ity to other foreign m aterial, e.g. bacteria, 
viruses and fungi. T h e  reader w ill be quick to 
p oin t out that these difficulties have not pre­
vented the successful transplantation of cor­
neas obtained from  cadavers. T h e  reason for 
this is that since cornea is an acellu lar and 
avascular structure, it is not sub ject to the cell 
m ediated im m une response m ounted b y  the 
recipient. A n y  process lead ing to vascularis- 
ation o f the gra ft results in its rapid rejection.
E ven  a cursory study o f the com plex nature 
o f the im m u ne m echanism  w ill suggest that 
it m ay be possible to in terrupt it at several 
poin ts by agents w h ich  in terfere w ith  cellu lar 
m ultip lication  or fu nction . In fact num erous 
m ethods o f im m unosuppression have been 
developed, and som e have found application  
in hum an transplantation .
I r ra d ia t io n
W h o le  body irradiation using about 15 0  
rads was used about a decade ago in the early
days o f renal transplantation . Irradiation 
interferes w ith  the m olecular structure of 
desoxyribonucleic acid, and thus w ith cell 
division, cells being m ost susceptib le to this 
in jury during early m itosis. T h e  tissues m ost 
affected  b y  this treatm ent, therefore, arc those 
w hich  divide m ost rapidly, nam ely, th e  cells 
o f the bone m arrow , lym ph oreticu lar system , 
skin , and m ucous m em branes. In practice, 
the use o f a non-specific agent o f this nature 
m ay result in a dangerous and prolonged 
p ancytopaen ia. T h is , and the difficulties of 
choosing the correct dose to su it each case led 
to its early d iscontinuation as a clin ical 
im m unosuppressant. N onetheless local irradi­
ation o f the graft, b y  destroying cells in filtrat­
ing the organ, and in the regional lym p h  nodes, 
is th ought b y  som e to be o f value in the treat­
m ent o f rejection crises.
A n t im e tabo l i tes
It  is possible to in terfere w ith  nucleic acid 
synthesis in other w ays, how ever. T h e  anti- 
m etabolite  6-m ercaptopurine , b y  its sim ilarity 
to certain naturally  occurring purine com ­
pounds, can m od ify  purine m etabolism , thus 
in terferin g  w ith  the production o f nucleo- 
protein and therefore w ith  cell d ivision. It  
also should be expected to affect all d ivid ing 
cells, but in com parison w ith irradiation it has 
the advantage of m anoeuvrab ility, the effect of 
a change in dose being m ore rapidly seen than 
in the case o f irrad iation. D esp ite  this advan­
tage, 6-m ercaptopurine itself does not prove to 
be a very suitable agent fo r hum an use, be­
cause o f the h igh incid ence of toxic side effects. 
Investigation  o f a large num ber o f related 
com pounds led to the developm ent in  19 59  
o f azathioprine, a derivative o f 6-m ercapto- 
purine w ith broadly sim ilar effects but w ith 
m uch b etter patient tolerance. T h is  agent 
holds a position o f great im portance in hum an 
transplantation , and has been largely respons­
ib le for the im provem ent in renal transplant 
survival in the past decade.
Corticosteroids
T h e  ab ility  o f corticosteroids to suppress 
in flam m atory responses, in cluding the im m une 
response to transplants has long been know n. 
T h e ir  m ode o f action is not clear, and although 
in som e species, e.g. rabbits, guinea pigs and- 
m ice, cortisone prolongs the survival o f skin 
grafts, in others, e.g. dogs, m onkeys and
humans, it is ineffective when given alone. As 
an adjunctive treatment to azathioprine, pred­
nisone has come to play an important part in 
clinical immunosuppression. Large doses of 
prednisone, e.g. 2-4 mg. per kilogram, are 
effective in reversing acute rejection pheno­
mena, and in fact, in the case of renal trans­
plants, many patients become dependent on 
a dose of 0 .2 5 -0 .5  mg. per kilogram.
Actinomycin
Actinom ycin C  is a mixture of a group of 
antibiotic substances derived from Strepto- 
myccs chrysomallus which has a cytotoxic 
effect. T h is appears to take the form of an 
interference in the control which desoxyribo­
nucleic acid exerts over messenger ribo-nucleic 
acid. It is most useful in the treatment of 
rejection crisis, when it is given as a short 
course of one or two intravenous injections 
in conjunction with increased doses of pred­
nisone and maximal doses of azathioprine.
Antilymphocytic globulin
T h e above agents, by their nature, have an 
effect on all the cells and tissues of the body, 
and therefore produce various unwanted side 
effects. T h e  antimetabolite and cytotoxic 
drugs may be responsible for agranulocytosis, 
thrombocytopaenia, ulceration of the alim en­
tary mucosa, and loss of hair. Prolonged 
treatment with steroids produces the typical 
Cushingoid facies, with triae, moon face, 
osteoporosis, and increased incidence of hyper­
tension and peptic ulceration. It  has long 
been hoped that a more specific agent m ight 
be produced which would inhibit the m ech­
anisms primarily responsible for transplant 
im m unity without at the same time interfer­
ing with resistance to bacterial infection, or 
damaging other important groups of cells, e.g. 
the epithelial cells of the alimentary tract. T o  
some extent, these hopes are fulfilled b y anti­
lym phocytic serum, which has recently been the 
subject of intense study in many laboratories 
throughout the world, and has been used in 
a number of cases of renal transplantation. 
T h e  concept of an antilym phocytic serum is 
not new, and such a serum was prepared as 
early as 19 37  by Chew  and Lawrence, who 
demonstrated its ability to suppress the peri­
pheral blood lym phocyte count in vivo. Similar 
suppression was obtained by W oodruff, W o od ­
ruff and Form an in 1950 8 when it was noted
that the lym phopenia was relatively short­
lived; because of this, it was at that time 
thought that antilym phocytic serum would be 
unlikely to have a significant influence on 
allograft survival.
Slight prolongation of skin graft survival 
was shown in 19 61 by W aksm an, Arbouys and 
Arnason,7 but later observations in Edinburgh 
by W oodruff and Anderson, in 1963 and 1964,9 
demonstrated that skin graft survival in rats 
could be significantly prolonged by the admin­
istration of a scrum raised in horses against 
rat lymphocytes. It was then shown that pro­
longed lymphopenia was not a necessary pre­
requisite for graft survival. In the past four 
years, extensive research into the production 
and properties of these sera has been carried 
out, and highly significant contributions have 
been made in our own m edical school.
Antilym phocytic serum is made by injecting 
a preparation of the lymphocytes of the species 
in which grafting is to be carried out into 
another species. Usually the serum is raised 
in a large animal for transplant experiments 
in a smaller animal, for example, horse anti­
dog serum, rabbit anti-mouse serum, and so 
on. It is possible to prepare cell suspensions 
rich in lymphocytes from spleen, thymus, 
lym ph nodes, thoracic duct lym ph, or peri­
pheral blood. After a course of active im m un­
isation by these cells, the animal is bled and 
the scrum so obtained is heated to 56 °C  to 
destroy complement.
A t this stage dangerous anti-erythrocyte 
activity is present, irrespective of the origin 
of the innoculated lym phocyte suspensions; 
the scrum also contains large amounts of un­
wanted protein which must be removed. 
Purification may be carried out by several 
techniques, but our method has been to carry 
out sodium sulphate precipitation and batch 
chromatography on diethylaminoethyl cellu­
lose, restoring the salt concentration to physio­
logical levels by dialysis prior to storage at 
— 2 0 °C . T h e  final preparation consists of 
immunoglobulin G , or Ig G  for short. It is 
absorbed against red cell stroma and platelets 
in order to reduce its activity against these 
elements in treated animals.
Anim al experiments have shown that anti­
lym phocytic globulin (A LG ) possesses power­
ful immunological properties. Fo r instance, it 
has been shown to suppress the production of 
humoral antibodies to primary immunisation 
by numerous antigens; it can inhibit cutaneous 
phenomena which are due to the cellular re-
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sponse of delayed hypersensitivity, for example, 
the tuberculin reaction; it can prolong the 
survival of allografts of skin, kidney and other 
tissues, and it can modify the course of certain 
auto-immune diseases, 'for example allergic 
encephalomyelitis in mice.
Evidence is now available, notably from 
Starzl in Denver, 110 that A L G , used in con­
junction with reduced doses of azathioprine 
and prednisone, gives results in human renal 
transplantation that are at least as good as, 
and probably better than, those obtained with 
these agents administered together in their 
usual dosage. Since both azathioprine and 
prednisone have potentially serious side effects, 
this observation is highly significant. H ow ­
ever, this powerful new tool is not w ithout its 
problems; its antiplatelet activity is sometimes 
troublesome, and the injection is often pain­
ful. Although it is able to suppress humoral 
and cellular immunity, it is itself a foreign 
protein, and in fact it has been shown to be 
if anything more antigenic than normal gamma 
globulin derived from the same source. The 
reason for this probably lies in the fact that 
it homes onto lymphocytes which, being 
altered in some way, are taken up by macro­
phages resulting in the absorbed A L G  being 
concentrated in the very centre of the treated 
animal’s immune defence mechanism.
The mode of action of antilymphocytic 
globulin is only partly understood. There is 
no doubt that the active molecules in an A L G  
preparation adhere to lymphocytes, but what 
they do in this situation is less certain. Three 
main theories have been advanced; that the 
lymphocytes are destroyed by A LG ; that their 
cell membrane is so occupied by A L G  mole­
cules that it is unable to respond in the normal 
way to other antigens (blind-folding); and that 
lymphocytes are transformed into a type of cell 
which is immunologically inactive (sterile in ­
activation). Space will not allow a discussion 
of these and other theories, and the experi­
mental evidence which supports or refutes 
them, for which the reader is referred to spec­
ific works on the subject.1
TI SS UE  T Y P I N G
These then arc the ways at present available 
to overcome the homograft reaction. At best 
they arc imperfect tools, and therefore the 
problems involved in avoiding or minimising 
rejection achieve the greater importance. The 
laws governing the transfusion of blood which
concern the A B O  grouping system must not 
be transgressed. Rhesus antigens are of much 
less importance, as are the numerous antigens 
which have been identified on the red cell 
membrane. In  recent years attention has been 
turned to antigenic determinants which arc 
present in the leucocytes of peripheral blood. 
Pioneers in this field have been Terasaki in 
Los Angeles, Dausset, Van Rood and Cepellini 
in Europe, and Batchelor in London. They 
have collected sera from patients who have 
been sensitised to foreign leucocytes, for ex­
ample from pregnant women, or from people 
who have received multiple blood transfusions. 
The antibody content of these sera has been 
characterised and it is possible by their use 
to define which antigens are present on a given 
patient’s cells, and to correlate the degree of 
compatibility between recipient and donor 
with the clinical course of a transplant. Evalu­
ation of leucocyte typing continues, but it 
would appear already that there is in many 
(but not all) eases a correlation between high 
donor-host compatibility and smooth clinical 
course, free from rejection episodes. That 
some cases of complete compatibility never­
theless develop a rejection crisis may be taken 
as evidence that there arc other parameters of 
compatibility testing of which we are not as 
yet aware. Among them may be preformed 
humoral antibodies, particularly in the case of 
kidney recipients who may have been trans­
fused with scores of bottles of blood during 
their period of rehabilitation on dialysis prior 
to transplantation. Although the importance 
of such antibodies has been doubted’ it may­
be necessary to revise this view when sufficient 
information becomes available.
B A C T E R I O L O G I C A L  P R O B L E M S
The management of patients on im m uno­
suppressive treatment presents certain prob­
lems, especially in the case of renal transplants 
where general resistance to infection is d im ­
inished and the rate of excretion of drugs 
uncertain. The effects of a change in dosage 
of azathioprine arc not seen for a few days, 
and it is sometimes very difficult, demanding 
considerable experience, to negotiate the nar­
row way between too little suppression, with 
the dangers of rejection, and too much, with 
the equally unwelcome dangers of infection. 
It is because of this problem that it is preferred 
to manage these patients in a sterile area such 
as has been constructed at the Nuffield Trans-
plantation U n it in E d in b u rgh , w here all pos­
sible precautions such as the design of the 
unit, an elaborate ventilation system , bacterial 
surveys and decontam ination  o f nursing and 
m edical staff, have been taken to m inim ise 
the colonisation o f the patient by organism s 
other than his ow n.
A R T I F I C I A L  A I D S  TO VISCERAL F U N C T IO N
A  patient w ho is in the term inal stages of 
disease of one of his visceral organs, be it k id ­
ney, liver, lung or heart, such that his only 
'hope is transplantation o f a new  organ, is 
usually in a desperate clinical state. Looking 
back at the early days o f renal transplantation, 
there is no doubt that a great deal o f the 
peri-operative m ortality, and the early failures, 
were due to the fact that the recipients were 
often m oribund, having been saved from  death 
itself by one or tw o hair-raising h aem odialyses. 
T h e  developm ents in dialysis technology in 
the early 19 6 0 ’s, leading to the introduction 
by Scribner of long term in term ittent dialysis 
for chronic renal failure, transform ed the 
situation in two ways. F irstly , an alternative 
to transplantation becam e available in w hat 
has becom e known as repeated dialysis treat­
m ent or, by that habit o f abbreviation to w hich 
m edical m en are so addicted, as “ R .D .T .”  
Secondly, repeated dialysis treatm ent allows a 
patient w ith  term inal renal failure to be re­
h ab ilitated  so that his physical condition is no 
longer a bar to the relatively m ajor operation 
o f transplantation w ith its attendant hazards 
relating to im m unosuppression. Such com ­
plications as hypertension, oedem a, ascites, 
congestive heart failure and in fections can 
usually be elim inated or controlled during this 
period, leading to a greatly im proved chance 
o f surviving the operation.
F o r  som e patients, notably those w ith  lower 
urinary tract anom alies or disease, transplant­
ation is not successful, and m anagem ent by 
R .D .T . is preferable. O pin ions m ay differ as 
to w hether and when a patient successfully 
launched onto repeated dialysis should have 
his transplant, b u t since dialysis treatm ent and 
transplants fail fo r entirely unrelated reasons, 
a com bination o f the two m ethods o f treat­
m ent can sign ificantly prolong the life  expect­
ancy o f patients with term inal renal failure.
W h e n  one surveys the transform ation that 
repeated dialysis treatm ent has brought to the 
scene o f renal transplantation, one is bound
to ask how sim ilar facilities, if available w ould 
a fleet hepatic and cardiac transplantation. 
Perhaps the greatest advances in these 
branches of transplantation surgery in the next 
decade w ill be the developm ent of artificial 
aids capable o f adequate patient rehabilitation.
T H E  W A Y  A H E A D
Lo o kin g to the fu ture, there are several 
problem s in transplantation surgery w hich re­
quire careful thought and w ell directed re­
search. O n e  o f the m ost d ifficu lt o f these is 
the procurem ent o f organs. O f necessity, 
cardiac and liver transplants arc obtained from  
cadaver donors, but so also are a large propor­
tion o f renal grafts. In the latter case suffic­
ient tim e is available to ensure that by all 
necessary criteria, death has occurred. A  m ore 
urgent tim e scale in the case o f the liver, and, 
in the case o f the heart, cessation o f function 
in the organ to be transplanted being a previ­
ously essential criterion of dem ise, has led to 
serious suspicions o f am bivalence on the part 
o f the physicians responsible fo r the treatm ent 
o f the donor, and o f excessive zeal on the part 
of the w ould be transplanters. F o r  our part 
we have gone to great lengths to avoid any 
influence w hatever in the good treatm ent of 
any potential donor, and have preferred to 
allow  an organ to pass by rather than becom e 
the ob ject o f such suspicions. It is quite clear 
that a period of several years w ill be necessary 
in which painstaking effort is applied to the 
form ing of public opin ion , and perhaps new 
legislation enacted to facilitate the procure­
m ent of organs w hile safeguarding the inter­
ests o f the potential donor.
H aving obtained an organ for transplant­
ation , tim e is vital, and the com plex logistic 
problem s involved in m obilising the surgical 
team , the recipient, and such ancillary services 
as for exam ple, blood transfusion, blood coag­
ulation and clin ical chem istry w ould be m uch 
sim pler if the organ could be stored in a viable 
state for a num ber o f hours or even days. C e r­
tain advances have been m ade along these lines 
in the ease o f the kidney, and, m ore recently, 
the liver, using hypotherm ic perfusion with 
electro lyte solutions, b lood, low  m olecular 
w eight dextran, m annitol, or com binations of 
these m aterials, in conjunction w ith hyper­
baric oxygen and, when tem peratures below  
freezing point have been em ployed, such anti- 
freezing agents as dim ethyl sulph oxide . T h ese  
crude m ethods have allow ed experim ental pre­
servation of the kidney for up to 24 hours in
26
a viable state, but m uch greater reliability 
w ould be required before they could justify 
so great a delay in a case o f hum an transplant­
ation.
T h e  im m unological battle is the central and 
m ost d ifficu lt problem  to be solved. Im proved
m ethods o f tissue m atching, and m ore specific 
im m unosuppression probably along the lines 
o f antilym ph ocytic  globulin , w ill no doubt be 
developed, but there rem ains the im m un­
ologist’s dream  that specific tole rance to an 
organ transplant m ay one day com e w ithin the 
bounds of clinical possibility.
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DIAGNOSTIC PROBLEM
S E T  B Y  A.  S T R O N G .  B . A . ( Oxo n ) ,  M.B. ,  Ch.B.
S U B J E C T
M iss A . B ., aged 18 . R ig h t handed.
P R I N C I P A L  C O M P L A I N T S
T rem or, paraesthesiac, obesity, headache.
H I S T O R Y
( 1)  T rem or, im pairm ent of fine m ovem ents 
and paraesthesiac o f the right side, princi­
pally  o f the arm . T h e  trem or worst at 
rest and exacerbated by concentration. 
T h re e  m onths’ duration and steadily de­
teriorating.
(2) Increase in appetite and w eight and exces­
sive thirst fo r three weeks.
(5) Frontal headache 011 rising in the m orning 
for the past three weeks.
(4) G eneral m edical and fam ily histories neg­
ative.
G E N E R A L  E X A M I N A T I O N
A  tall, obese girl : otherw ise negative : blood 
pressure norm al.
N E U R O L O G I C A L  E X A M I N A T I O N
1 .  In te llect not significantly im paired : no 
intracranial b ru its : no p ap illoedema.
2. S ligh t slurring of speech.
•5. M ild  right facial weakness of central 
pattern.
4. Sensation depressed on right side of face 
and right arm.
5. Severe resting trem or of right arm and leg.
6. Increased tone o f right l im b s : equivocal 
right plantar response : drags the right foot on 
w alking.
7. N o inco-ordination or rom bergism .
I N V E S T I G A T I O N S
R o u tin e  haem atology and biochem istry nor­
m al; C S F  pressure and protein norm al.
Scrum  co rtiso ls : (a) 1 1  p .m . —  8 µg / 10 0  m l. 
(b) 9 a.m , —  1 1  µg / 10 0  m l.
A . W h e re  is the lesion and w hat is it likely
to be?
B . W h a t neurological investigations arc re­
quired?
F U R T H E R  P R O G R E S S
A fter investigation a diagnosis was m ade and 
in view  o f her rapid deterioration the patient 
underw ent craniotom y in an attem pt to arrest 
the expansion of her lesion. D urin g  surgery 
there was m arked venous oozing. Post- 
operatively she was slow  to recover conscious­
ness and suddenly deteriorated 18  hours later. 
Re-exploration showed an accum ulation o f clot 
from  recurrent venous oozing. She rem ained 
deeply unconscious and som e 24 hours later 
developed an intense ja u n d ic e : urobilinogen 
and bilirubin appeared in the urine. Pro­
throm bin activity was 2 9 % , S .G .P .T . 570 I.U ., 
serum indirect bilirubin 2 .5 m g /10 0  m l, direct 
5.7 m g / 10 0  m l. B leed ing tim e was 9 m inutes : 
no increase in fibrin degradation products : 
direct and indirect coom bs’ tests n e g a t iv e : 
slight depression of vitam in K  —  dependent 
coagulation factors (II, V I I  and X ). In spite 
of treatm ent including triple strength plasm a 
and vitam in K 1 her condition deteriorated and 
she died 6 days after operation.
C . W h a t was the cause of her jaundice?
(Answer on page 48)
